Contact Us
Global Angioedema Treatment Market Report 2025

Angioedema Treatment Global Market Report 2025 - By Type (Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema), By Route Of Administration (Injection, Oral), By End Use (Hospitals, Clinics, Research Organizations) - Market Size, Trends, And Global Forecast 2025-2034

Angioedema Treatment Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : June 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Angioedema Treatment Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

What Is Covered Under Angioedema Treatment Market?

Angioedema treatment refers to the medical management of swelling beneath the skin or mucous membranes, often caused by an allergic reaction, medication side effects, or a genetic condition. This swelling can be triggered by allergic reactions, genetic conditions, medications, or sometimes unknown causes, and the treatment aims to reduce symptoms, prevent airway obstruction, and minimize the frequency and severity of attacks.

The main types of angioedema treatment include allergic angioedema, drug-induced angioedema, idiopathic angioedema, and hereditary angioedema. Allergic angioedema refers to swelling caused by an allergic reaction to substances such as foods, insect bites, or medications. It can be administered through injection and orally, catering to diverse end users, including hospitals and clinics, as well as research organizations.

Angioedema Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Angioedema Treatment Market Size 2025 And Growth Rate?

The angioedema treatment market size has grown rapidly in recent years. It will grow from $2.72 billion in 2024 to $3.13 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to increasing government support, a rise in diagnosis rates, a rise in autoimmune disorders, growth in clinical trials, and growth in healthcare infrastructure.

What Is The Angioedema Treatment Market Growth Forecast?

The angioedema treatment market size is expected to see rapid growth in the next few years. It will grow to $5.4 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to growing healthcare expenditure, increased allergy awareness, increasing prevalence of chronic diseases, rising incidence and prevalence of angioedema, and increasing focus on personalized medicine. Major trends in the forecast period include advancements in diagnostic technologies, machine learning integration, investments in research and development, telemedicine adoption, and regulatory approvals and faster market access.

How Is The Angioedema Treatment Market Segmented?

The angioedema treatment market covered in this report is segmented –

1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema

2) By Route Of Administration: Injection, Oral

3) By End Use: Hospitals, Clinics, Research Organizations

1) By Allergic Angioedema: Antihistamines, corticosteroids, epinephrine, Immunotherapy, Allergen Avoidance Therapies

2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors

3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management

4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

What Is Driving The Angioedema Treatment Market? Rise In Rare Disease Diagnoses Fueling The Growth Of The Market Due To Improving Genetic Testing And Diagnostics

A rise in the incidence of rare diseases is expected to propel the growth of the angioedema treatment market going forward. Rare diseases refer to medical conditions that affect a very small portion of the population, often with limited treatment options and significant health impacts. The occurrence of rare diseases is increasing due to advancements in genetic testing and diagnostic technologies that enable healthcare professionals to detect and accurately diagnose previously overlooked conditions, leading to a higher reported prevalence. Angioedema treatment is helpful for rare diseases such as hereditary angioedema by providing targeted therapies that help prevent and manage severe swelling episodes, improving patient outcomes. For instance, in November 2024, according to the Food and Drug Administration, a US-based federal agency, more than 7,000 rare diseases impacted over 30 million individuals in the United States. Therefore, the rise in the incidence of rare diseases is driving the growth of the angioedema treatment market.

Who Are The Major Players In The Global Angioedema Treatment Market?

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

What Are The Key Trends Of The Global Angioedema Treatment Market? Innovative Long-Term Preventive Therapy For Hereditary Angioedema

Major companies operating in the angioedema treatment market are focusing on developing innovative solutions, such as subcutaneous injections, to offer more convenient and rapid relief for patients suffering from acute hereditary angioedema (HAE) attacks. Subcutaneous injections are a method of delivering medication into the fatty tissue just beneath the skin for slow and steady absorption into the bloodstream. For instance, in April 2025, CSL Limited, an Australia-based biotechnology company, launched ANDEMBRY (garadacimab) as a novel, fully human monoclonal antibody treatment for preventing acute attacks in patients with hereditary angioedema (HAE). ANDEMBRY is the first pre-filled pen for once-monthly subcutaneous administration, offering a convenient long-term prophylactic option. The drug works by inhibiting activated Factor XII (Factor XIIa), a key initiator in the cascade leading to angioedema. It represents a significant advancement in HAE management by providing effective, patient-centric disease control.

What Are Latest Mergers And Acquisitions In The Angioedema Treatment Market? Ionis Pharmaceuticals Inc Partnered Otsuka Pharmaceutical Co., Ltd. To Enhance Hereditary Angioedema Treatment

In December 2023, Ionis Pharmaceuticals Inc., a US-based biotechnology company, partnered with Otsuka Pharmaceutical Co., Ltd. to commercialize donidalorsen in Europe for the treatment of hereditary angioedema. This partnership aims to accelerate the regulatory approval and commercialization of donidalorsen in Europe, making this innovative therapy available to hereditary angioedema patients through Otsuka’s regional expertise and market presence. Otsuka Pharmaceutical Co., Ltd. is a Japan-based pharmaceutical company that offers treatments for hereditary angioedema (HAE).

What Is The Regional Outlook For The Global Angioedema Treatment Market?

North America was the largest region in the angioedema treatment market in 2024. The regions covered in the angioedema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the angioedema treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Angioedema Treatment Market?

The angioedema treatment market consists of revenues earned by entities providing services, such as antihistamine administration, diagnostic services, corticosteroid therapy, genetic counseling, and immunology services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Angioedema Treatment Industry?

The angioedema treatment market research report is one of a series of new reports from The Business Research Company that provides angioedema treatment market statistics, including angioedema treatment industry global market size, regional shares, competitors with an angioedema treatment market share, detailed angioedema treatment market segments, market trends and opportunities, and any further data you may need to thrive in the angioedema treatment industry. This angioedema treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Angioedema Treatment Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $3.13 billion
Revenue Forecast In 2034 $5.4 billion
Growth Rate CAGR of 14.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The angioedema treatment market covered in this report is segmented –
1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema
2) By Route Of Administration: Injection, Oral
3) By End Use: Hospitals, Clinics, Research Organizations
1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies
2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors
3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management
4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Angioedema Treatment Market Characteristics

    3. Angioedema Treatment Market Trends And Strategies

    4. Angioedema Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Angioedema Treatment Growth Analysis And Strategic Analysis Framework

    5.1. Global Angioedema Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Angioedema Treatment Market Growth Rate Analysis

    5.4. Global Angioedema Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Angioedema Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Angioedema Treatment Total Addressable Market (TAM)

    6. Angioedema Treatment Market Segmentation

    6.1. Global Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Allergic Angioedema

    Drug-Induced Angioedema

    Idiopathic Angioedema

    Hereditary Angioedema (HAE)

    6.2. Global Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Injection

    Oral

    6.3. Global Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinics

    Research Organizations

    6.4. Global Angioedema Treatment Market, Sub-Segmentation Of Allergic Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Antihistamines

    Corticosteroids

    Epinephrine

    Immunotherapy

    Allergen Avoidance Therapies

    6.5. Global Angioedema Treatment Market, Sub-Segmentation Of Drug-Induced Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Discontinuation of Causative Drug

    Antihistamines

    Corticosteroids

    Epinephrine

    Bradykinin Pathway Inhibitors

    6.6. Global Angioedema Treatment Market, Sub-Segmentation Of Idiopathic Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Empirical Antihistamine Therapy

    Corticosteroid Therapy

    Leukotriene Receptor Antagonists

    Monoclonal Antibodies

    Observation And Symptom Management

    6.7. Global Angioedema Treatment Market, Sub-Segmentation Of Hereditary Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    C1 Esterase Inhibitor Replacement Therapy

    Bradykinin B2 Receptor Antagonists

    Kallikrein Inhibitors

    Attenuated Androgens

    Antifibrinolytics

    7. Angioedema Treatment Market Regional And Country Analysis

    7.1. Global Angioedema Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Angioedema Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Angioedema Treatment Market

    8.1. Asia-Pacific Angioedema Treatment Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Angioedema Treatment Market

    9.1. China Angioedema Treatment Market Overview

    9.2. China Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Angioedema Treatment Market

    10.1. India Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Angioedema Treatment Market

    11.1. Japan Angioedema Treatment Market Overview

    11.2. Japan Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Angioedema Treatment Market

    12.1. Australia Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Angioedema Treatment Market

    13.1. Indonesia Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Angioedema Treatment Market

    14.1. South Korea Angioedema Treatment Market Overview

    14.2. South Korea Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Angioedema Treatment Market

    15.1. Western Europe Angioedema Treatment Market Overview

    15.2. Western Europe Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Angioedema Treatment Market

    16.1. UK Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Angioedema Treatment Market

    17.1. Germany Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Angioedema Treatment Market

    18.1. France Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Angioedema Treatment Market

    19.1. Italy Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Angioedema Treatment Market

    20.1. Spain Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Angioedema Treatment Market

    21.1. Eastern Europe Angioedema Treatment Market Overview

    21.2. Eastern Europe Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Angioedema Treatment Market

    22.1. Russia Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Angioedema Treatment Market

    23.1. North America Angioedema Treatment Market Overview

    23.2. North America Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Angioedema Treatment Market

    24.1. USA Angioedema Treatment Market Overview

    24.2. USA Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Angioedema Treatment Market

    25.1. Canada Angioedema Treatment Market Overview

    25.2. Canada Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Angioedema Treatment Market

    26.1. South America Angioedema Treatment Market Overview

    26.2. South America Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Angioedema Treatment Market

    27.1. Brazil Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Angioedema Treatment Market

    28.1. Middle East Angioedema Treatment Market Overview

    28.2. Middle East Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Angioedema Treatment Market

    29.1. Africa Angioedema Treatment Market Overview

    29.2. Africa Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Angioedema Treatment Market Competitive Landscape And Company Profiles

    30.1. Angioedema Treatment Market Competitive Landscape

    30.2. Angioedema Treatment Market Company Profiles

    30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

    31. Angioedema Treatment Market Other Major And Innovative Companies

    31.1. Bausch Health Companies Inc.

    31.2. Apotex Inc.

    31.3. Aurobindo Pharma Ltd.

    31.4. Dr. Reddy’s Laboratories Ltd

    31.5. Cipla Inc.

    31.6. Alnylam Pharmaceuticals Inc

    31.7. Ionis Pharmaceuticals Inc.

    31.8. Salix Pharmaceuticals Ltd

    31.9. BioCryst Pharmaceuticals Inc.

    31.10. Pharming Group NV

    31.11. Pharvaris Netherlands B.V

    31.12. Astria Therapeutics

    31.13. Intellia Therapeutics

    31.14. KalVista Pharmaceuticals Ltd.

    31.15. ADARx Pharmaceuticals

    32. Global Angioedema Treatment Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Angioedema Treatment Market

    34. Recent Developments In The Angioedema Treatment Market

    35. Angioedema Treatment Market High Potential Countries, Segments and Strategies

    35.1 Angioedema Treatment Market In 2029 - Countries Offering Most New Opportunities

    35.2 Angioedema Treatment Market In 2029 - Segments Offering Most New Opportunities

    35.3 Angioedema Treatment Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Angioedema Treatment Market, Sub-Segmentation Of Allergic Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Angioedema Treatment Market, Sub-Segmentation Of Drug-Induced Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Angioedema Treatment Market, Sub-Segmentation Of Idiopathic Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Angioedema Treatment Market, Sub-Segmentation Of Hereditary Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Angioedema Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Angioedema Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Sanofi SA Financial Performance
  • Table 79: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 80: Viatris Inc. Financial Performance
  • Table 81: Otsuka Pharmaceutical Co. Ltd. Financial Performance
  • Table 82: Fresenius Kabi AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Angioedema Treatment Market, Sub-Segmentation Of Allergic Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Angioedema Treatment Market, Sub-Segmentation Of Drug-Induced Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Angioedema Treatment Market, Sub-Segmentation Of Idiopathic Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Angioedema Treatment Market, Sub-Segmentation Of Hereditary Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Angioedema Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Angioedema Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Sanofi SA Financial Performance
  • Figure 79: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 80: Viatris Inc. Financial Performance
  • Figure 81: Otsuka Pharmaceutical Co. Ltd. Financial Performance
  • Figure 82: Fresenius Kabi AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Angioedema Treatment market?

Angioedema treatment refers to the medical management of swelling beneath the skin or mucous membranes, often caused by an allergic reaction, medication side effects, or a genetic condition. This swelling can be triggered by allergic reactions, genetic conditions, medications, or sometimes unknown causes, and the treatment aims to reduce symptoms, prevent airway obstruction, and minimize the frequency and severity of attacks. For further insights on the Angioedema Treatment market, request a sample here

How will the Angioedema Treatment market drivers and restraints affect the market dynamics? What forces will shape the Angioedema Treatment industry going forward?

The Angioedema Treatment market major growth driver - Rise In Rare Disease Diagnoses Fueling The Growth Of The Market Due To Improving Genetic Testing And Diagnostics. For further insights on the Angioedema Treatment market, request a sample here

What is the forecast market size or the forecast market value of the Angioedema Treatment market?

The Angioedema Treatment market size has grown strongly in recent years. The angioedema treatment market size has grown rapidly in recent years. It will grow from $2.72 billion in 2024 to $3.13 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to increasing government support, a rise in diagnosis rates, a rise in autoimmune disorders, growth in clinical trials, and growth in healthcare infrastructure. The angioedema treatment market size is expected to see rapid growth in the next few years. It will grow to $5.4 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to growing healthcare expenditure, increased allergy awareness, increasing prevalence of chronic diseases, rising incidence and prevalence of angioedema, and increasing focus on personalized medicine. Major trends in the forecast period include advancements in diagnostic technologies, machine learning integration, investments in research and development, telemedicine adoption, and regulatory approvals and faster market access. For further insights on the Angioedema Treatment market, request a sample here

How is the Angioedema Treatment market segmented?

The angioedema treatment market covered in this report is segmented –
1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema
2) By Route Of Administration: Injection, Oral
3) By End Use: Hospitals, Clinics, Research Organizations
1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies
2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors
3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management
4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics For further insights on the Angioedema Treatment market,
request a sample here

Which region has the largest share of the Angioedema Treatment market? What are the other regions covered in the report?

North America was the largest region in the angioedema treatment market in 2024. The regions covered in the angioedema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Angioedema Treatment market, request a sample here.

Who are the major players in the Angioedema Treatment market?

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc. . For further insights on the Angioedema Treatment market, request a sample here.

What are the key trends in the Angioedema Treatment market?

Major trends in the Angioedema Treatment market include Innovative Long-Term Preventive Therapy For Hereditary Angioedema. For further insights on the Angioedema Treatment market, request a sample here.

What are the major opportunities in the Angioedema Treatment market? What are the strategies for the Angioedema Treatment market?

For detailed insights on the major opportunities and strategies in the Angioedema Treatment market, request a sample here.

How does the Angioedema Treatment market relate to the overall economy and other similar markets?

For detailed insights on Angioedema Treatment's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Angioedema Treatment industry?

For detailed insights on the mergers and acquisitions in the Angioedema Treatment industry, request a sample here.

What are the key dynamics influencing the Angioedema Treatment market growth? SWOT analysis of the Angioedema Treatment market.

For detailed insights on the key dynamics influencing the Angioedema Treatment market growth and SWOT analysis of the Angioedema Treatment industry, request a sample here.